Overview of current therapeutic options: session summary

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

The journal of prevention of Alzheimer's disease·2023

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Diabetes & metabolism·2017

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Diabetes & metabolism·2017

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

Diabetes & metabolism·2017

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1).

Diabetes, obesity & metabolism·2015

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Diabetes, obesity & metabolism·2015

Multiple 24-Hour Urinary Sodium and Potassium Excretions and Type 2 Diabetes Incidence.

Diabetes care·2026

Sarcopenic Obesity and Risk of Incident Type 2 Diabetes: A Prospective Cohort Study and Landmark Analysis From the UK Biobank.

Diabetes care·2026

Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia.

Diabetes care·2026

Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 Diabetes.

Diabetes care·2026

30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes.

Diabetes care·2026

Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.

Diabetes care·2026

An herbal formula alleviates hyperuricemia: Evidence from network pharmacology and in vivo experiments.

Combinatorial chemistry & high throughput screening·2026

Behavioral and Molecular Effects of Kamikihito and Mesenchymal Stem Cells in a Two-hit Model of Treatment-resistant Depression.

Current neuropharmacology·2026

Effect of Educational and Behavioral Interventions on Medication-Overuse Headache: A Systematic Review and Meta-Analysis.

Pain research & management·2026

Diffusion tensor imaging in chronic tension-type headache.

Frontiers in pain research (Lausanne, Switzerland)·2026

Multidimensional therapeutic advantages of <i>Smilax glabra</i> (<i>Tufuling</i>)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction.

Frontiers in endocrinology·2026

Evaluating combined acupuncture and antiresorptive therapy in Chinese women with postmenopausal osteoporosis: a systematic review and network meta-analysis.

Frontiers in endocrinology·2026

Related Experiment Videos

Overview of current therapeutic options: session summary

Related Concept Videos

Initial Experiences with Amyloid-Related Imaging Abnormalities in Patients Receiving Aducanumab Following Accelerated Approval.

Assessment of hypoglycaemia during basal insulin therapy: Temporal distribution and risk of events using a predefined or an expanded definition of nocturnal events.

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

Glycaemic control and hypoglycaemia with insulin glargine 300 U/mL compared with glargine 100 U/mL in Japanese adults with type 2 diabetes using basal insulin plus oral anti-hyperglycaemic drugs (EDITION JP 2 randomised 12-month trial including 6-month extension).

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1).

New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2).

Multiple 24-Hour Urinary Sodium and Potassium Excretions and Type 2 Diabetes Incidence.

Sarcopenic Obesity and Risk of Incident Type 2 Diabetes: A Prospective Cohort Study and Landmark Analysis From the UK Biobank.

Effects of the Omnipod 5 Hybrid Closed-Loop System in People With Type 1 Diabetes With Impaired Awareness of Hypoglycemia.

Detectable C-Peptide and Diabetic Ketoacidosis Risk in Type 1 Diabetes.

30-Year Trends in Microvascular Complications and Treatment in Adolescents With Type 1 Diabetes.

Type 1 Diabetes Driven by Residual Recipient T Cells After Hematopoietic Cell Transplantation: A Case Report.

An herbal formula alleviates hyperuricemia: Evidence from network pharmacology and in vivo experiments.

Behavioral and Molecular Effects of Kamikihito and Mesenchymal Stem Cells in a Two-hit Model of Treatment-resistant Depression.

Effect of Educational and Behavioral Interventions on Medication-Overuse Headache: A Systematic Review and Meta-Analysis.

Diffusion tensor imaging in chronic tension-type headache.

Multidimensional therapeutic advantages of <i>Smilax glabra</i> (<i>Tufuling</i>)-containing formulae in gout: an integrated Systematic Review and network pharmacology-based prediction.

Evaluating combined acupuncture and antiresorptive therapy in Chinese women with postmenopausal osteoporosis: a systematic review and network meta-analysis.

Related Experiment Videos

Overview of current therapeutic options: session summary

Related Concept Videos

Related Articles